Related Experiment Video

Updated: Aug 7, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

[Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis]

Yun-shan Guo1, Wei-jie Yuan, Jian-ping Yu

  • 1Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

Zhonghua Xin Xue Guan Bing Za Zhi
|June 17, 2006
PubMed

Insights

Hypertensive nephrosclerosis (HN) was misdiagnosed in nearly 25% of patients. Renal biopsy is crucial for accurate diagnosis, as clinical features overlap with primary nephritis and focal segmental glomerulosclerosis.

Area of Science:

  • Nephrology
  • Pathology
  • Hypertension Research

Context:

  • Clinically presumed hypertensive nephrosclerosis (HN) diagnosis can be challenging.
  • Distinguishing HN from other renal diseases is critical for appropriate patient management.

Purpose:

  • To evaluate the clinical and pathological characteristics of patients with presumed HN.
  • To determine the accuracy of clinical diagnosis for HN.

Summary:

  • A study of 63 patients with presumed HN found that renal biopsy confirmed HN in 74.6%.
  • Primary nephritis and focal segmental glomerulosclerosis (FSGS) were diagnosed in 16 patients, highlighting diagnostic challenges.
  • HN patients exhibited distinct clinical features including higher age and longer hypertension duration, but key indicators like blood pressure and GFR were similar across groups.

Impact:

  • Findings underscore the high rate of misdiagnosis for HN, emphasizing the need for renal biopsy.
  • Accurate diagnosis of HN is essential for guiding treatment and improving patient outcomes in hypertensive kidney disease.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...